TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Adesso Bioproducts AS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
84,588
|
111,393
|
76,881 |
| Financial expenses |
1,070
|
639
|
364 |
| Earnings before taxes |
4,762
|
7,065
|
5,183 |
| Total assets |
65,457
|
85,245
|
83,247 |
| Current assets |
49,140
|
68,194
|
65,952 |
| Current liabilities |
23,694
|
44,414
|
48,901 |
| Equity capital |
41,070
|
40,011
|
33,470 |
| - share capital |
102
|
109
|
106 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.7%
|
46.9%
|
40.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.6%
|
6.3%
|
6.7% |
| Return on assets (ROA) |
8.9%
|
9.0%
|
6.7% |
| Current ratio |
207.4%
|
153.5%
|
134.9% |
| Return on equity (ROE) |
11.6%
|
17.7%
|
15.5% |
| Change turnover |
-19,425
|
32,130
|
16,198 |
| Change turnover % |
-19%
|
41%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.